Expression of Fas and Fas ligand in human testicular germ cell tumours

International Journal of Andrology

Volumn 32, Issue 2, 2009, Pages 123-130

  Baldini, E ^a   Ulisse, S ^a   Marchioni, E ^a   Di Benedetto, A ^a   Giovannetti, G ^a   Petrangeli, E ^a   Sentinelli, S ^b   Donnorso, R P ^b   Reale, M G ^a   Mottolese, M ^b   Gandini, L ^a   Lenzi, A ^a   D'Armiento, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Fas; FasL; Germ cells; Seminoma; Testis; Tumour

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; PARAFFIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MALE; ORCHIECTOMY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINOMA; TESTIS; TUMOR VOLUME; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; DISEASE COURSE; GENETICS; METABOLISM; MIDDLE AGED; TESTIS TUMOR; YOUNG ADULT;

ADULT; ANTIGENS, CD95; DISEASE PROGRESSION; FAS LIGAND PROTEIN; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 61849174680     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2007.00823.x     Document Type: Article

References (47)

1. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. Duke, R. C. (1995) A role for CD95 ligand in preventing graft rejection. Nature 377, 630 632.
2. Botti, C., Buglioni, S., Benevolo, M., Giannarelli, D., Papaldo, P., Cognetti, F. et al. (2004) Altered expression of Fas system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy. Clinical Cancer Research 10, 1360 1365.
3. Braendstrup, O., Bols, B. Jensen, L. (1996) Fas and Fas-ligand expression in seminomatous testes. APMIS 107, 431 436.
4. Braun, R. E. (1998) Early sperm is sacred or is it? Nature Genetics 18, 202 204.
5. Bray, F., Richiardi, L., Ekbom, A., Pukkala, E., Cuninkova, M. Møller, H. (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increase in incidence and declines in mortality. International Journal of Cancer 118, 3099 3111.
6. Chomczynski, P. Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156 159.
7. von Eyben, F. E., Jacobsen, G. K. Skotheim, R. I. (2005) Microinvasive germ cell tumor of the testis. Virchows Archiv: An International Journal of Pathology 447, 610 625.
8. Francavilla, S., D'Abrizio, P., Cordeschi, G., Pelliccione, F., Decozione, S., Ulisse, S., Properzi, G. Francavilla, F. (2002) Fas expression correlates with human germ cell degeneration in meiotic and post-meiotic arrest of spermatogenesis. Molecular Human Reproduction 8, 213 220.
9. Furuya, Y., Fuse, H. Masai, M. (2001) Serum soluble Fas level for detection and staging of prostate cancer. Anticancer Research 21, 3595 3598.
10. Gillette-Ferguson, I. Sidman, C. L. (1994) A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. European Journal of Immunology 24, 1181 1185.
11. Gratas, C., Tohma, Y., Barnas, C., Taniere, P., Hainaut, P. Ohgaki, H. (1998) Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Research 15, 2057 2062.
12. Griffith, T. S. Ferguson, T. A. (1997) The role of FasL-induced apoptosis in immune privilege. Immunology 18, 240 244.
13. Grobholz, R., Zentgraf, H., Kohrmann, K. U. Bleyl, U. (2002) Bax, Bcl-2, fas and Fas-L antigen expression in human seminoma: correlation with the apoptotic index. APMIS 110, 724 732.
14. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E. et al. (1996) Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 22, 1363 1366.
15. Hara, S., Miyake, H., Nakamura, I., Arakawa, S., Kamidono, S. Hara, I. (2001) Increased Fas ligand expression in the tumor tissue and serum of patients with testicular germ cell tumors with seminomatous elements. Urology 58, 471 476.
16. Kersemaekers, A. M., van Weeren, P. C., Oosterhuis, J. W. Looijenga, L. H. (2002) Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis. Journal of Pathology 196, 423 429.
17. Kim, Y. S., Kim, K. H., Choi, J. A., Lee, J. H., Kim, H. K., Won, N. H. Kim, I. (2000) Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors. Archives of Pathology & Laboratory Medicine 124, 687 693.
18. Kondera-Anasz, Z., Mielczarek-Palacz, A. Sikora, J. (2005) Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors. Apoptosis 10, 1143 1149.
19. Looijenga, L. H. Oosterhuis, J. W. (1999) Pathogenesis of testicular germ cell tumors. Reviews of Reproduction 4, 90 100.
20. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Flers, W. Schulze-Osthoff, K. (1995) Requirement of an ICE/CED-3 protease for CD95/APO-1-mediated apoptosis. Nature 375, 81 83.
21. McClure, R. F., Heppelmann, C. J. Paya, C. V. (1999) Constitutive Fas ligand gene transcription in Sertoli cells is regulated by SP1. Journal of Biological Chemistry 274, 7756 7762.
22. Medema, J. P. (1997) FLICE is activated by association with the CD95 death-inducing signalling complex (DISC). EMBO Journal 16, 2794 2804.
23. Mizutani, Y., Hongo, F., Sato, N., Ogawa, O., Yoshida, O. Miki, T. (2001) Significance of serum soluble Fas ligand in patients with bladder carcinoma. Cancer 15, 287 293.
24. Mottolese, M., Buglioni, S., Bracalenti, C., Cardarelli, M. A., Ciabocco, L., Giannarelli, D., Botti, C., Natali, P. G., Concetti, A. Venanzi, F. M. (2000) Prognostic relevance of altered Fas (CD95)-system in human breast cancer. International Journal of Cancer 20, 127 132.
25. Nagata, S. Golstein, P. (1995) The Fas death factor. Science 267, 1449 1456.
26. Niehans, G. A., Brunner, T., Frizelle, S. P., Liston, J. C., Salerno, C. T., Knapp, D. J., Green, D. R. Kratzke, R. A. (1997) Human lung carcinomas express Fas ligand. Cancer Research 57, 1007 1012.
27. O'Connell, J., O'Sullivan, G. C., Collins, J. K. Shanahan, F. (1996) The Fas counter attack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. Journal of Experimental Medicine 184, 1075 1082.
28. Oosterhuis, J. W. Looijenga, L. H. J. (2005) Testicular germ cell tumours in a broader perspective. Nature Reviews. Cancer 5, 210 222.
29. Pentikäinen, V., Erkkila, K. Dunkel, L. (1999) Fas regulates germ cell apoptosis in the human testis in vitro. American Journal of Physiology 276, E310 E316.
30. Ramsdell, F., Seaman, M. S., Miller, R. E., Tough, T. W., Alderson, M. R. Lynch, D. H. (1994) gld/gld mice are unable to express a functional ligand for Fas. European Journal of Immunology 24, 928 933.
31. Restifo, N. P. (2000) Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nature Medicine 6, 493 495.
32. Riccioli, A., Dal Secco, V., De Cesaris, P., Starace, D., Gandini, L., Lenzi, A., Dondero, F., Padula, F., Filippini, A. Ziparo, E. (2005) Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen. Human Reproduction 20, 2814 2820.
33. Richburg, J. H., Nañez, A., Williams, L. R., Embree, M. E. Boekelheide, K. (2000) Sensitivity of testicular germ cells to toxicant-induced apoptosis in gld mice that express a nonfunctional form of Fas ligand. Endocrinology 141, 787 793.
34. Rodriguez, I., Ody, C., Araki, K., Garcia, I. Vassalli, P. (1997) An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO Journal 16, 2262 2270.
35. Schmelz, H. U., Abend, M., Kraft, K., Hauck, E. W., Weidner, W., Van Beuningen, D. Sparwasser, C. (2002) Fas/Fas ligand system and apoptosis induction in testicular carcinoma. Cancer 95, 73 81.
36. Shimizu, M., Kondo, M., Ito, Y., Kume, H., Suzuki, R. Yamaki, K. (2005) Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Cancer Detection and Prevention 29, 175 180.
37. Sokoloff, M. H., Joyce, G. F., Wise, M. Urologic Disease in American Project. (2007) Testis cancer. Journal of Urology 177, 2030 2041.
38. Spierings, D. C. J., de Vries, E. G. E., Vellenga, E. de Jong, S. (2003a) The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli. Journal of Pathology 200, 137 148.
39. Spierings, D.C., de Vries, E. G., Vellenga, E. de Jong, S. (2003b) Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line. Cell Death and Differentiation 10, 808 822.
40. Suda, T., Takahashi, T., Golstein, P. Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169 1178.
41. Takayama, H., Takakuwa, T., Tsujimoto, Y., Tani, Y., Nonomura, N., Okuyama, A., Nagata, S. Aozasa, K. (2002) Frequent Fas gene mutations in testicular germ cell tumors. American Journal of Pathology 161, 635 641.
42. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F. et al. (1996) Fas ligand in human serum. Nature Medicine 2, 317 322.
43. Ulisse, S., Cinque, B., Silvano, G., Rucci, N., Biordi, L., Cifone, M. G. D'Armiento, M. (2000) Erk-dependent cytosolic phospholipase A2 activity id induced by CD95 ligand cross-linking in the mouse derived Sertoli cell line TM4 and is required to trigger apoptosis in CD95 bearing cells. Cell Death and Differentiation 7, 916 924.
44. Vargo-Gogola, T., Crawford, H. C., Fingleton, B. Matrisian, L. M. (2002) Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Archives of Biochemistry and Biophysics 408, 155 161.
45. Viard-Leveugle, I., Veyrenc, S., French, L. E., Brambilla, C. Brambilla, E. (2003) Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. The Journal of Pathology 201, 268 277.
46. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A. Nagata, S. (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. Journal of Immunology 148, 1274 1279.
47. Yu, X., Kubota, H., Wang, R., Saegusa, J., Ogawa, Y., Ichihara, G., Takeuchi, Y. Hisanaga, N. (2001) Involvement of bcl-2 family genes and Fas signaling system in primary and secondary male germ cell apoptosis induced by 2-bromopropane in rat. Toxicology and Applied Pharmacology 174, 35 48.